The Nanotechnology Study Section (NANO) reviews applications focused on research in bioengineering and technology development relating to the unique properties of nanomaterials. Nanotechnology draws from the disciplines of bioengineering, materials science, chemistry, physics and relevant biological/biomedical areas. Novel nanotechnology development, coupled with anticipated applications in various biological/biomedical fields is typical.
The List of Reviewers lists all present, whether permanent or temporary, to provide the full scope of expertise present on that date. Lists are posted 30 days before the meeting and are tentative, pending any last minute changes.
The membership panel is a list of chartered members only.
- Nanotechnology based research in complex biological/biomedical problems.
- Design, synthesis, and development of nanostructures, nanodevices, and nanosystems for various biological/biomedical applications.
- Multifunctional nanoparticles in cellular imaging, sensing, targeted drug/gene delivery and theranostics.
- Studies of the unique properties of nanomaterials.
- Biocompatibility and toxicities associated with nanomaterials.
Shared Interests and Overlaps
There are shared interests with Biomaterials and Biointerfaces Study Section (BMBI). Applications that focus on the biocompatibility and toxicities associated with nanomaterials may be assigned to NANO. Applications that address the use of nanomaterial based approaches for tissue engineering may be assigned to BMBI.
There are shared interests with Cellular and Molecular Technologies (CMT). Applications focused on material development and characterization may be assigned to NANO. Applications more focused on the use of nanomaterials to address cellular and molecular processes may be assigned to CMT.
There are shared interests with Gene and Drug Delivery Systems (GDD) in the area of nano-therapeutics. Applications focused on the synthesis, chemical properties, biodistribution, and toxicology of nanoparticle-based delivery platforms may be assigned to NANO. Applications that focus on viral vectors or biological delivery issues involving the use of nanoparticles may be assigned to GDD.
There are shared interests with Instrumentation and Systems Development (ISD). Applications developing biosensing or technologies involving the development of novel nanostructures or functionalize nanoparticles may be assigned to NANO. Applications developing biosensing or technologies that are more device-based may be assigned to ISD.
There are shared interests with Medical Imaging (MEDI). Applications developing nanomaterial-based imaging contrast agents may be assigned to NANO. Applications developing other medical imaging systems or related technologies may be assigned to MEDI.